Vigabatrin Market | Amneal Pharma, Benta Pharma Industries, Cipla
Vigabatrin Market | Amneal Pharma, Benta Pharma Industries, Cipla
Source: pr-inside.com
Partial Onset Seizures News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Partial Onset Seizures. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Partial Onset Seizures Today - Breaking & Trending Today
Partial-Onset Seizures Market By Indication (Simple Focal Seizures, Complex Focal Seizures, Secondar
250 Pages Partial-Onset Seizures Market Survey by Fact MR, A Leading Business and Competitive Intelligence ProviderSeizures is a brain disorder characterized by a sudden, uncontrolled electrical disturbance in the brain. It involves changes in behavior, body movements or feelings, and consciousness levels of a patie...
Source: pharmiweb.com
USFDA: Zydus Cadila gets USFDA tentative nod for epilepsy treatment drug
Zydus Cadila has received tentative approval from the US Food and Drug Administration (USFDA) to market Brivaracetam tablets, in the strengths of 10 mg, 25 mg, 50 mg, 75 mg, and 100 mg, Cadila Healthcare said in a regulatory filing.
Source: indiatimes.com
Eisai Presents Breadth of Data Across Neurology Portfolio, Including Alzheimer's Disease, Insomnia and Epilepsy
Eisai Presents Breadth of Data Across Neurology Portfolio, Including Alzheimer's Disease, Insomnia and Epilepsy Twenty-one presentations featuring data and information on investigational lecanemab in early Alzheimer's disease, DAYVIGO® (lemborexant) CIV in insomnia, FYCOMPA® (perampanel) CIII in epilepsy and investigational lorcaserin in Dravet Syndrome News provided by Share this article Share this article WOODCLIFF LAKE, N.J., April 16, 2021 /PRNewswire/ -- Eisai Inc., the U.S. pharmaceutical subsidiary of Eisai Co., Ltd., announced today that data from the company's deep neurology pipeli...
Source: prnewswire.com